1-10 of 10
Young H. Kim
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 3235: Activation-inducible TNFR family receptor (AITR) signaling mediates the polarization of CD4+ T cells into Th1, Th2, and Th17, converts Treg to Teff and eradicates solid tumors

Free
Byoung S. Kwon, Seung J. Lee, Young H. Kim, Joong W. Lee, Sun H. Hwang, Dass S. Vinay
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 3235.
https://doi.org/10.1158/1538-7445.AM2019-3235
Published: 01 July 2019
View articletitled, Abstract 3235: Activation-inducible TNFR family receptor (AITR) signaling mediates the polarization of CD4+ T cells into Th1, Th2, and Th17, converts Treg to Teff and eradicates solid tumors
Journal Articles

Steroid Receptor Coactivator-3 Expression in Lung Cancer and Its Role in the Regulation of Cancer Cell Survival and Proliferation

Free
Di Cai, David S. Shames, Maria Gabriela Raso, Yang Xie, Young H. Kim, Jonathan R. Pollack, Luc Girard, James P. Sullivan, Boning Gao, Michael Peyton, Meera Nanjundan, Lauren Byers, John Heymach, Gordon Mills, Adi F. Gazdar, Ignacio Wistuba, Thomas Kodadek, John D. Minna
Journal: Cancer Research
Cancer Res (2010) 70 (16): 6477–6485.
https://doi.org/10.1158/0008-5472.CAN-10-0005
Published: 14 August 2010
View articletitled, Steroid Receptor Coactivator-3 Expression in Lung Cancer and Its Role in the Regulation of Cancer Cell Survival and Proliferation
Open the PDF for Steroid Receptor Coactivator-3 Expression in Lung Cancer and Its Role in the Regulation of Cancer Cell Survival and Proliferation in another window
Includes: Supplementary data
Journal Articles

Combination Therapy with Cisplatin and Anti–4-1BB: Synergistic Anticancer Effects and Amelioration of Cisplatin-Induced Nephrotoxicity

Free
Young H. Kim, Beom K. Choi, Kwang H. Kim, Sang W. Kang, Byoung S. Kwon
Journal: Cancer Research
Cancer Res (2008) 68 (18): 7264–7269.
https://doi.org/10.1158/0008-5472.CAN-08-1365
Published: 14 September 2008
View articletitled, Combination Therapy with Cisplatin and Anti–4-1BB: Synergistic Anticancer Effects and Amelioration of Cisplatin-Induced Nephrotoxicity
Open the PDF for Combination Therapy with Cisplatin and Anti–4-1BB: Synergistic Anticancer Effects and Amelioration of Cisplatin-Induced Nephrotoxicity in another window
Includes: Supplementary data
Journal Articles

Mechanisms Involved in Synergistic Anticancer Immunity of Anti-4-1BB and Anti-CD4 Therapy

Free
Beom K. Choi, Young H. Kim, Woo J. Kang, Sun K. Lee, Kwang H. Kim, Su M. Shin, Wayne M. Yokoyama, Tae Y. Kim, Byoung S. Kwon
Journal: Cancer Research
Cancer Res (2007) 67 (18): 8891–8899.
https://doi.org/10.1158/0008-5472.CAN-07-1056
Published: 17 September 2007
View articletitled, Mechanisms Involved in Synergistic Anticancer Immunity of Anti-4-1BB and Anti-CD4 Therapy
Open the PDF for Mechanisms Involved in Synergistic Anticancer Immunity of Anti-4-1BB and Anti-CD4 Therapy in another window
Includes: Supplementary data
Journal Articles

A Gene Expression Signature of Genetic Instability in Colon Cancer

Free
Craig P. Giacomini, Suet Yi Leung, Xin Chen, Siu Tsan Yuen, Young H. Kim, Eric Bair, Jonathan R. Pollack
Journal: Cancer Research
Cancer Res (2005) 65 (20): 9200–9205.
https://doi.org/10.1158/0008-5472.CAN-04-4163
Published: 17 October 2005
View articletitled, A Gene Expression Signature of Genetic Instability in Colon Cancer
Open the PDF for A Gene Expression Signature of Genetic Instability in Colon Cancer in another window
Includes: Supplementary data
Journal Articles

Microarray analysis of small cell lung cancer reveals altered apoptotic imbalance and distinct expression signatures of MYC family gene amplification

Free
Young H. Kim, Luc Girard, Craig Giacomini, Pei Wang, Tina Hernandez-Boussard, Robert Tibshirani, John D. Minna, Jonathan R. Pollack
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 206.
Published: 01 May 2005
View articletitled, Microarray analysis of small cell lung cancer reveals altered apoptotic imbalance and distinct expression signatures of MYC family gene amplification
Journal Articles

Aberrant Epidermal Growth Factor Receptor Signaling and Enhanced Sensitivity to EGFR Inhibitors in Lung Cancer

Free
Joseph Amann, Shailaja Kalyankrishna, Pierre P. Massion, Joyce E. Ohm, Luc Girard, Hisayuki Shigematsu, Michael Peyton, Denise Juroske, Yuhui Huang, J. Stuart Salmon, Young H. Kim, Jonathan R. Pollack, Kiyoshi Yanagisawa, Adi Gazdar, John D. Minna, Jonathan M. Kurie, David P. Carbone
Journal: Cancer Research
Cancer Res (2005) 65 (1): 226–235.
https://doi.org/10.1158/0008-5472.226.65.1
Published: 21 January 2005
View articletitled, Aberrant Epidermal Growth Factor Receptor Signaling and Enhanced Sensitivity to EGFR Inhibitors in Lung Cancer
Open the PDF for Aberrant Epidermal Growth Factor Receptor Signaling and Enhanced Sensitivity to EGFR Inhibitors in Lung Cancer in another window
Journal Articles

Localization of novel pancreatic cancer genes by CGH on cDNA microarrays

Free
Murali D. Bashyam, Young H. Kim, Anirban Maitra, Jonathan R. Pollack
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 655.
Published: 01 April 2004
View articletitled, Localization of novel pancreatic cancer genes by CGH on cDNA microarrays
Journal Articles

Microarray analysis of gene copy number and expression in lung cancer

Free
Young H. Kim, Luc Girard, John D. Minna, Jonathan R. Pollack
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 654–655.
Published: 01 April 2004
View articletitled, Microarray analysis of gene copy number and expression in lung cancer
Journal Articles

SU5416 Is a Potent and Selective Inhibitor of the Vascular Endothelial Growth Factor Receptor (Flk-1/KDR) That Inhibits Tyrosine Kinase Catalysis, Tumor Vascularization, and Growth of Multiple Tumor Types

Free
T. Annie T. Fong, Laura K. Shawver, Li Sun, Cho Tang, Harald App, T. Jeff Powell, Young H. Kim, Randall Schreck, Xueyan Wang, Werner Risau, Axel Ullrich, K. Peter Hirth, Gerald McMahon
Journal: Cancer Research
Cancer Res (1999) 59 (1): 99–106.
Published: 01 January 1999
View articletitled, SU5416 Is a Potent and Selective Inhibitor of the Vascular Endothelial Growth Factor Receptor (Flk-1/KDR) That Inhibits Tyrosine Kinase Catalysis, Tumor Vascularization, and Growth of Multiple Tumor Types
Open the PDF for SU5416 Is a Potent and Selective Inhibitor of the Vascular Endothelial Growth Factor Receptor (Flk-1/KDR) That Inhibits Tyrosine Kinase Catalysis, Tumor Vascularization, and Growth of Multiple Tumor Types in another window